• phone icon. 301-251-6638
    • Contact Us
    • Request a Quote
    • About Us
    • Distributors
    • Careers
    • 301-251-6638
    • Technical ResourcesTechnical
      Resources
      • Technical Resources
      • Citations & Testimonials
      • Order Support
      • FAQ
    • My Account
      My Account
      • Log In
      • Create Account
    • My Cart My Cart
      My Cart 1
    MENUMENU
    • Viral Packaging Services
      • AAV Packaging
      • Adenovirus Packaging
      • Lentivirus Packaging
      • Analytical Services
    • cGMP Services
      • cGMP AAV Production
      • cGMP Adenovirus Production
      • cGMP Lentivirus Production
      • cGMP Retrovirus Production
      • cGMP Custom Virus Production
      • Cell & Virus Banking
      • Aseptic Filling
      • Plasmid Manufacturing
      • cGMP QC Services
      • cGMP Process Development
      • IND/IMPD Services
    • Cloning Services
      • Molecular Cloning
      • Gene Synthesis & Mutagenesis
      • shRNA Cloning
      • CRISPR/Cas9 Cloning
    • Products
          • AAV Products
            • AAV Controls
            • AAV Biosensors
            • AAV Parkinson's Disease Tools
            • AAV Zika ORFs
          • Reference Standards
            • AAV Full Capsids
            • AAV Empty Capsids
          • Adenovirus Products
            • Adenovirus Controls
            • Adenovirus ORFs
            • Adenovirus miRNAs
            • Adenovirus Zika ORFs
          • Lentivirus Products
            • Lentivirus Controls
            • Lentivirus ORFs
          • Plasmid Products
            • Shuttle Vectors & Promoters
            • Plasmid ORFs
            • Plasmid miRNAs
            • Plasmid Zika ORFs
            • Plasmid shRNAs
          • GMP-ReadyTM/GMP Plasmids
            • AAV pHelper-Kan
    • Technologies
      • Upstream
      • Downstream
      • Producer Cell Lines
      • Facilities
    • Home
    • News & Events
    • Press Releases
    • Vigene and ASC Therapeutics Announce Long-Term Strategic Partnership for Gene Therapy Development and Manufacturing

    Vigene and ASC Therapeutics Announce Long-Term Strategic Partnership for Gene Therapy Development and Manufacturing

    ROCKVILLE, Md. Vigene Biosciences, Inc. (Vigene), a leading biotechnology company for viral vector production and development for cell and gene therapies, announced today that it has entered into a long-term strategic manufacturing partnership with ASC Therapeutics (“ASC”), a California-based gene therapy company focused on developing transformative gene-based medicines for serious diseases. Vigene will provide ASC with access to GMP manufacturing including viral vectors and plasmid DNA for its hemophilia A gene therapy clinical program, as well as a manufacturing platform for future gene therapy programs.

    “The genetic platform technology developed by ASC is going to change the way serious diseases are treated in the future. We have seen remarkable potency data in our Hemophilia A IND-enabling gene therapy studies,” said Dr. Ruhong Jiang, ASC Founder & CEO.

    Dr. Jiang continued, “We are proud to welcome Vigene, a global leader in gene therapy process development and GMP manufacturing with a proven track record and expertise in the field of viral vector manufacturing, to become an integral part of ASC long-term plan. Our partnership provides ASC access to Vigene’s world-class team with expertise for both plasmid DNA and viral vector manufacturing as well as high-caliber QC and QA teams.”

    “Vigene is excited to become a long-term CMC partner for ASC with multiple newly built, state-of-the-art GMP suites and high-titer virus producer cell lines, we are well positioned to support ASC for both early-stage and commercial virus production. This partnership will ensure that all ASC clinical deliverables are achieved in a timely fashion,” said Dr. Zairen Sun, Vigene’s President and CEO. “We have a world-class manufacturing team, and this agreement is a testimony for our recognition by top-tier biopharmaceutical companies.”

    About ASC Therapeutics

    ASC Therapeutics is a biopharmaceutical company dedicated to advancing an integrated and sustainable pipeline focused on gene therapies that correct the root cause of complex and intractable diseases. We are leveraging our AAV-based gene therapy, CRISPR-Cas9 and proprietary gene editing platforms consolidated over 10 years to develop transformative gene-based medicines. ASC is accelerating through clinical trials several lead gene therapies for inherited blood disorders. Our team of industry veterans in discovery, pre-clinical, clinical and CMC gene therapy development and world-class academic and biopharmaceutical partnerships are potentiating our gene therapy capabilities. To learn more about ASC Therapeutics, please visit www.asctherapeutics.com.

    About Vigene Biosciences

    Vigene Biosciences is an award-winning and private equity backed leader in gene delivery development and manufacturing. Vigene has 16 years of cGMP viral vector production experience. Vigene’s mission is to make gene therapy affordable. Vigene offers IND-enabling and IND-supporting materials as well as FDA- and EMA-compliant commercial products for plasmid, AAV, lentivirus, and adenovirus with proven technologies and track records. The GMP facility features 10 GMP suites including 5 brand-new cGMP suites with 200L-500L single-use stir tank bioreactors for suspension cells as well as iCellis 500 for adherent cells. In 2018 and 2019 Vigene was recognized by INC500. In 2018, Vigene was chosen as the ACG Emerging Company of the Year Award. To learn more about Vigene Biosciences, please visit www.vigenebio.com

    ASC Contact Information:
    Oscar Segurado, MD, PhD
    Chief Medical Officer
    ASC Therapeutics
    Milpitas, CA
    650.490.5199
    [email protected]

    Vigene Contact Information:
    Jeffrey Hung, Ph.D.
    Chief Commercial Officer
    Vigene Biosciences
    Rockville, MD
    301.251.6638
    [email protected]

    Viral Packaging Services

    • AAV Packaging
    • Adenovirus Packaging
    • Lentivirus Packaging
    • Analytical Services

    cGMP Services

    • cGMP AAV Production
    • cGMP Adenovirus Production
    • cGMP Lentivirus Production
    • cGMP Retrovirus Production
    • cGMP Custom Virus Production
    • Cell & Virus Banking
    • Aseptic Filling
    • Plasmid Manufacturing
    • cGMP QC Services
    • cGMP Process Development
    • IND/IMPD Services

    Cloning Services

    • Molecular Cloning
    • Gene Synthesis & Mutagenesis
    • shRNA Cloning
    • CRISPR/Cas9 Cloning

    Products

    • AAV Products
    • Adenovirus Products
    • Lentivirus Products
    • Plasmid Products

    Technologies

    • Upstream
    • Downstream
    • Producer Cell Lines
    • Facilities

    Resources

    • Technical Resources
    • Citations & Testimonials
    • FAQ

    About

    • Company
    • Newsroom
    • Leadership
    • Careers

    Contact

    • Contact Us
    • Request a Quote
    • How to Order
    • Distributors

    Address

    5 Research Court
    Rockville, MD 20850 USA

    Stay Connected

    Copyright 2019 Vigene Biosciences. All Rights Reserved. Terms and Conditions | Privacy Policy
      INC500-ACG-ARM-BETTER-TOGETHER-COVID19